<乌鸦传媒>MACRA Gets Mixed Reviews at House Hearing Despite good intentions, it hasn't solved Medicare's physician payment issues, experts say Jun 22, 2023
<乌鸦传媒>Controversial Gene Therapy Wins FDA Approval for Duchenne Muscular Dystrophy Sarepta's treatment gets a nod for ambulatory pediatric patients Jun 22, 2023
<乌鸦传媒>Another Online SARMs Retailer Gets a Warning From the FDA Warrior Labz SARMS markets several drugs they claim could address weight loss, muscle growth Jun 22, 2023
<乌鸦传媒>A Year Later, Doctors Feel Impact of Dobbs Decision 'Every Single Day' "Sometimes, I feel that I am not able to fulfill the Hippocratic Oath" Jun 21, 2023
<乌鸦传媒>First SGLT2 Inhibitor Approved for Kids With Type 2 Diabetes Now another oral option other than metformin Jun 21, 2023
<乌鸦传媒>Colchicine's Rebirth as Cardiovascular Drug Approved by FDA Repurposed anti-inflammatory drug may be used alone or in combination with standard meds Jun 20, 2023
<乌鸦传媒>The Supreme Court Delivers an Unexpected Win for Medicaid Recipients An important accountability measure has been upheld Jun 17, 2023
<乌鸦传媒>New Bispecific Antibody Approved for Tough-to-Treat Lymphoma Approval of glofitamab was based on a phase I/II study that showed a 56% overall response rate Jun 16, 2023
<乌鸦传媒>Biden Picks Next CDC Director Mandy Cohen has "proven track record protecting Americans' health and safety," the president says Jun 16, 2023
<乌鸦传媒>MedPAC Recommends Cutting Admin Fees Paid to Docs Under Part B Program The goal is to make providers more sensitive to drug costs, says MedPAC's director Jun 15, 2023
<乌鸦传媒>'We Need It Now': AMA Delegates Urge Public Health System Funding, Support COVID-era funding is drying up as Medicaid rolls are shrinking Jun 15, 2023
<乌鸦传媒>AMA Declares Payment Reform an 'Urgent' Priority Delegates to hold leaders accountable for progress Jun 13, 2023
<乌鸦传媒>Alzheimer's Drug Clears Major Hurdle Toward Full Approval But risks associated with anti-amyloid agent lecanemab still loom Jun 09, 2023
<乌鸦传媒>Did FDA Apply Rigorous Standards in Approving Paxlovid? Evidence for all relevant studies should be accessible Jun 09, 2023
<乌鸦传媒>Antibody for Infant RSV Prevention to Face FDA Panel Nirsevimab shot also a possibility for some at-risk toddlers Jun 06, 2023
<乌鸦传媒>Is Getting Test Results Online Right Away a Good Idea? Yes, Patients Say But more resources should be available to help them when the news is bad, one expert suggests Jun 06, 2023
<乌鸦传媒>How I Became a Physician on Food Stamps Expanded SNAP work requirements will do more harm than good Jun 06, 2023
<乌鸦传媒>How a Medical Recoding May Limit Cancer Patients鈥� Options for Breast Reconstruction Many believe this would restrict women's options for surgery Jun 04, 2023
<乌鸦传媒>FDA Warns on Certain Forms of Compounded Semaglutide Some products may not contain the same active ingredient as the approved drugs Jun 01, 2023
<乌鸦传媒>FDA OKs Olaparib-Abiraterone for Metastatic Prostate Cancer Approval limited to BRCA-positive subset Jun 01, 2023
<乌鸦传媒>Second RSV Vaccine Lands Approval for Older Adults Abrysvo approved for adults 60 and up Jun 01, 2023
<乌鸦传媒>What Happens When We Classify Kids' Weight as a 'Disease'? The AAP obesity guidelines stand to worsen stigma and mental health May 27, 2023
<乌鸦传媒>Sotagliflozin Gets FDA's Blessing for Heart Failure SGLT1/SGLT2 inhibitor approved on the basis of SOLOIST-WHF, SCORED trials May 27, 2023
<乌鸦传媒>House Passes Bill to Address Fentanyl Overdoses But critics say the HALT Fentanyl Act is the wrong way to approach the problem May 26, 2023
<乌鸦传媒>OTC Hearing Aids Are Here, but Are They Shaking Things Up? The market is still sorting itself out, experts say May 25, 2023
<乌鸦传媒>Another Texas Hospital Under Investigation for Youth Gender-Affirming Services Attorney General Paxton announced probe into Texas Children's Hospital May 23, 2023
<乌鸦传媒>Tackling Barriers to OTC Birth Control Pills FDA approval would be a critical step, but we must address other access issues May 23, 2023
<乌鸦传媒>New Type of Opioid Reversal Agent Approved Longer-acting nasal spray to be available by end of the year May 23, 2023
<乌鸦传媒>Ocaliva for NASH Gets Thumbs Down From FDA Advisors Difficulty of risk mitigation for potential drug-induced liver injury weighed heavily on members May 19, 2023
<乌鸦传媒>Rare Skin Blistering Condition Gets First Drug Approved FDA's decision marks first approval for a redosable gene therapy May 19, 2023
<乌鸦传媒>FDA 'Leans In' to Accelerated Approval for Rare Disease Drugs CBER director says "moment is tender for gene therapy," sees opportunity to "salvage" treatments May 19, 2023
<乌鸦传媒>Return of Rule Nixing Delivery of Rx Drugs to Medicare Patients Drawing Docs' Ire "It is endangering the lives of the oldest and sickest Americans," oncology group says May 18, 2023
<乌鸦传媒>Should FDA Grant Accelerated Approval to Duchenne Muscular Dystrophy Gene Therapy? Waiting for the results of the SRP-9001 confirmatory trial may be a better move May 18, 2023
<乌鸦传媒>First JAK Inhibitor Approved for Crohn's Disease Upadacitinib lands indication for moderately to severely active disease in adults May 18, 2023
<乌鸦传媒>Addiction Doc Urges Lawmakers to Rethink Methadone Prescribing Restrictions Suicide prevention in traumatic brain injury survivors also on the docket during hearing May 18, 2023
<乌鸦传媒>NASH Drug Candidate Comes With 'Serious Risks,' Says FDA Staff Agency reviewers signal little support for first potential nonalcoholic steatohepatitis drug May 17, 2023
<乌鸦传媒>The Broader Significance of a New Drug for a Rare Form of ALS The tofersen trial offers hope and lessons for the fight against ALS May 15, 2023
<乌鸦传媒>Duchenne Muscular Dystrophy Treatment Narrowly Captures Support of FDA Advisors Whether vote means FDA will approve Sarepta's gene therapy remains to be seen May 13, 2023
<乌鸦传媒>FDA OKs Hormone-Free Pill for Hot Flashes First-in-class drug works by blocking the NK3 receptor, which plays role in regulating body temp May 12, 2023
<乌鸦传媒>Bill to Study Xylazine Passes House, Advances in Senate Measure does not address scheduling the drug, which is frequently added to fentanyl May 12, 2023
